BioSpace News Archive

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company”, or “Pulse Biosciences”) today announced that it filed a registration statement on Form S-3 with the Securities and Exchange Commission (the “SEC”) for a rights offering to its existing stockholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company’s common stock, par value $0.001

Lundbeck today announced that VYEPTI™ (eptinezumab-jjmr), the first and only intravenous (IV) treatment for migraine prevention, is now commercially available in the U.S. and can be obtained via select specialty distributors and specialty pharmacies.

The first masks featuring the filter technology are being used as part of a project to supply masks to Minnesota’s M Health Fairview network

The international iReceptor Plus consortium is offering the technology tools and infrastructure developed within the EU-funded project, to facilitate the sharing and analyses of antibody and T-cell receptor sequencing (AIRR-seq) data from COVID-19 patients as soon as these data become available.

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the fourth quarter and year ended December 31, 2019.

A recent report by Transparency Market Research states that global wearable medical devices market is projected to witness a substantial growth.

Rising statistics of infection incidence and genetic cancer cases are main factors influencing growth of RNAi technology market.

Transparency Market Research has published a new report titled, ‘Transcatheter Embolization and Occlusion Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global microbiology culture market was valued at US$ 5.7 Bn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027.

The global medical imaging analysis software market is expanding at a respectable pace in recent times.